My Mounjaro Journey Week 31 - Mounjaro's Bitter End
Hello I’m not very happy at all. After confidently telling you that my Mounjaro medication was protected by my 12-month contract with SheMed, it turns out that it isn’t. I can continue, but the cost will increase from £99 to £279 every four weeks. They’re offering everyone the option of switching to Wegovy instead, and I think that’s what I’m going to have to do. I could afford the increase, but I just can’t justify it when there’s a cheaper alternative. What this means is that my Mounjaro journey will be over in four weeks’ time, so I’ll either have to change the name of my blog or bring it to a close and start a new one. As you can imagine, lots of people are feeling anxious about switching to Wegovy because it doesn’t work in quite the same way as Mounjaro. Both are GLP-1 receptor agonists—a molecule that binds to a receptor and activates it, triggering a biological response—but Mounjaro mimics two hormones: GLP-1 and GIP. GLP-1 is released after you eat and sends a signal to your b...